Injectable xyloglucan hydrogels incorporating spheroids of adipose stem cells for bone and cartilage regeneration

Cartilage or bone regeneration approaches based on the direct injection of mesenchymal stem cells (MSCs) at the lesion site encounter several challenges, related to uncontrolled cell spreading and differentiation, reduced cell viability and poor engrafting. This work presents a simple and versatile...

Full description

Saved in:
Bibliographic Details
Published inMaterials Science & Engineering C Vol. 131; p. 112545
Main Authors Muscolino, Emanuela, Di Stefano, Anna Barbara, Trapani, Marco, Sabatino, Maria Antonietta, Giacomazza, Daniela, Moschella, Francesco, Cordova, Adriana, Toia, Francesca, Dispenza, Clelia
Format Journal Article
LanguageEnglish
Published Lausanne Elsevier B.V 01.12.2021
Elsevier BV
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cartilage or bone regeneration approaches based on the direct injection of mesenchymal stem cells (MSCs) at the lesion site encounter several challenges, related to uncontrolled cell spreading and differentiation, reduced cell viability and poor engrafting. This work presents a simple and versatile strategy based on the synergic combination of in-situ forming hydrogels and spheroids of adipose stem cells (SASCs) with great potential for minimally invasive regenerative interventions aimed to threat bone and cartilage defects. Aqueous dispersions of partially degalactosylated xyloglucan (dXG) are mixed with SASCs derived from liposuction and either a chondroinductive or an osteoinductive medium. The dispersions rapidly set into hydrogels when temperature is brought to 37 °C. The physico-chemical and mechanical properties of the hydrogels are controlled by polymer concentration. The hydrogels, during 21 day incubation at 37 °C, undergo significant structural rearrangements that support cell proliferation and spreading. In formulations containing 1%w dXG cell viability increases up to 300% for SASCs-derived osteoblasts and up to 1000% for SASCs-derived chondrocytes if compared with control 2D cultures. The successful differentiation into the target cells is supported by the expression of lineage-specific genes. Cell-cell and cell-matrix interactions are also investigated. All formulations resulted injectable, and the incorporated cells are fully viable after injection. [Display omitted] •Partially degalactosilated xyloglucan (dXG) dispersed in inductive media rapidly set into gels at 37°C•The physical networks undergo significant reorganization during incubation for 21 days•Gels provide control of stem cell differentiation towards a single cell lineage•1%w dXG gels show 300% viability for osteocytes and 1000% in chondrocytes after 21 days.•Cells mixed with the gels and injected through small gauge syringe needles retain viability
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0928-4931
1873-0191
DOI:10.1016/j.msec.2021.112545